Epinephrine versus norepinephrine in cardiogenic shock: a systematic review and meta-analysis of adjusted clinical outcomes
Vasoactive therapy is central to the management of cardiogenic shock (CS). Although current guidelines recommend norepinephrine as the first-line vasopressor, epinephrine remains used in clinical practice, particularly in advanced shock states. Comparative evidence on clinical outcomes remains limited and predomi...